Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market Report Suite for Europe | 2017-2023 | MedSuite | Cerebrospinal Fluid Management, Detachable Coils, Liquid Embolics, Neurovascular Catheters and Guidewires, Neurovascular Stents, Neuromodulation Devices, Stereotactic Devices, Ultrasonic Aspirators, Neurosurgical Microscopes, Mechanical Thrombectomy, Transcranial Magnetic Stimulators

Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market Report Suite for Europe | 2017-2023 | MedSuite | Cerebrospinal Fluid Management, Detachable Coils, Liquid Embolics, Neurovascular Catheters and Guidewires, Neurovascular Stents, Neuromodulation Devices, Stereotactic Devices, Ultrasonic Aspirators, Neurosurgical Microscopes, Mechanical Thrombectomy, Transcranial Magnetic Stimulators

0

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 12/1/2016
  • Pages: 793
  • Type: MedSuite

The full report suite on the European market for neurological devices includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular catheters, neurovascular guidewires, neurovascular stents, neuromodulation devices, stereotactic devivces, ultrasonic aspirators, neurosurgical microscopes, mechanical thrombectomy devices, and transcranial magnetic simulators.

Major Segments Covered in the Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market Suite

Overall, the neurological device market was valued at nearly €882 million in 2016. This is expected to increase over the forecast period at a CAGR of 4.2% to approach €1.18 billion.

The full report suite on the European market for neurological devices includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular catheters, neurovascular guidewires, neurovascular stents, neuromodulation devices, stereotactic devices, ultrasonic aspirators, neurosurgical microscopes, mechanical thrombectomy devices, and transcranial magnetic simulators.

While this report suite contains all neurological device data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the neurological market research that you need. You can view these separate reports and segmentation here:

 

Of course, buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Ask for a Quote to Learn More

Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market Market Trends

The fastest growing segment in the neurological device market in 2016 was for mechanical thrombectomy devices. This market involves two segments: snare retrievers and thrombectomy catheters. These innovative devices offer a longer period of time after symptom onset of ischemic stroke to treat patients and can offer drastically improved clinical outcomes over current treatments. As clinical evidence increases there should be steady growth in this market over the forecast period. The neurovascular guidewire market is also experiencing rapid growth since they are required for use with mechanical thrombectomy as well as various other neurological procedures.

The neuromodulation market is also experiencing steady growth. The fastest growing segment within this market is sacral nerve stimulation. These devices have been found to be highly efficacious with the majority of patients opting to get replacements which continues to drive unit sales as awareness increases among patients and new sales increase as well. Several countries are impacted by reimbursement with a limited number of implants allowed every year. The Netherlands for example is a capitated market but physicians have been requesting permission to complete more implants since patients find them so efficacious. The price is also stable since Medtronic is the only competitor in the market; however, Axonics also received a CE mark in 2016 for a device in this market which may significantly impact trends.

The market with the lowest growth in 2016 was the detachable coil segment. Unit sales of detachable coils will be threatened by new technology which will cannibalize aneurysm treatment procedures. As more aneurysms are treated by new technology and those remaining use fewer coils, there will be a decrease in unit sales. In addition, the market has moved away from the use of coated detachable coils which commanded a higher premium than the bare platinum coils which are now used the majority of the time.

The neurovascular stent market will also experience low growth since traditional stents are often used for stent assisted coiling procedures. The decrease in the detachable coil market will therefore decrease the stent market as well. The market for flow diverter stents is also decreasing since their ASP is declining as there is an increase in unit sold and increased competitive pressure.

Another market experiencing slow growth is the ultrasonic aspirator market. The market is saturated and has become predominantly a replacement business. The technological advances have slowed drastically. The technology has been entering other markets where it is experiencing growth; however, it has stayed quite flat in the neurological space. The ASP has come down significantly over the years. This downward trend was seen within the market beginning in 2009. The market is under price pressure and competitors are playing against one another to either gain or maintain share.

To read more about the Europe neurological device market trends, take a look at our latest Expert Article from our Analysts:

Penumbra, Medtronic Lead Europe Mechanical Thrombectomy Market Fueled by Favorable Clinical Trials for the Treatment of Ischemic Stroke

Neurological Device Market Report Data Types

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2023, and Historical Data to 2013
  • Market Drivers & Limiters for Each Neurological Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Neurological Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles for Top Competitors
  • Related Press Releases from Top Competitors

Neurological Device  Companies Analyzed

Medtronic acquired several competitors (most notably Covidien), making them the leading competitor in in the neurological device market. They are the leading competitor in many segments such as neuromodulation, liquid embolics and neurovascular stents.

Abbott Laboratories announced in April 2016 that they will acquire St. Jude Medical who has been gaining market share in neuromodulation. They recently released new products in deep brain stimulation and are also top competitors in spinal cord stimulation.

Axonics recently gained CE mark approval for a sacral nerve stimulator which is posed to challenge the sole competitor, Medtronic, in this market.

Other notable contenders in the neurological device market include Stryker in the neurovascular and neurosurgical markets, Codman & Shurtleff Inc. in the cerebrospinal fluid management and neurovascular markets and Nevro in neuromodulation.

History of Our Neurological Device Market Research

We’ve been doing market research for medical devices for over a decade. We specialize in it, and the neurological market was one of our original reports that helped build trust in our research and methodology. We have built relationships with the top competitors in the neurological device market so that we can gather proprietary information in confidence to assure more accurate research, that our partners and clients then benefit from.

Because we’re a third party researcher, we have the ability to reach well into the top neurological device companies and look at a multi-angle approach to our research. Not only do we consider financial filings, we conduct interviews, use hospital and procedural databases, and our own history of research to create a picture of the market that’s incredibly accurate.

Our clients have used our neurological device market research for years to strategize new markets to break into, submit SEC filings, decide sales and marketing strategies, plan acquisitions and product launches, and provide a 3rd party source to show investors, boards, and senior executives.









Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×